Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FRCQM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,355
Award facts
- Contract value 100% obligated
- $20,355.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,355.38 for Cosentyx (secukinumab) 300mg dose in 2ml pen format on July 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
This award represents a continuation of AmerisourceBergen's established role as a critical pharmaceutical distributor for federal military and veteran healthcare systems. Cosentyx, a specialty immunosuppressant medication, supports the Defense Health Agency's medical supply requirements for military personnel and beneficiaries. As the prime contractor on the SPE2DX IDC, AmerisourceBergen demonstrates significant capacity to deliver pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs globally. The competitive award affirms the contractor's ability to meet federal procurement standards and supply requirements across the defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FRCQM?
SPE2DB25FRCQM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FRCQM worth?
The government has obligated $20,355 on SPE2DB25FRCQM.
Is contract SPE2DB25FRCQM an order under another contract?
Yes. SPE2DB25FRCQM is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRCQM competed?
The extent of competition for SPE2DB25FRCQM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award